The Influence of Two Different CO2 Absorbers on Sevoflurane Consumption During Anaesthesia
NCT04271462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2021-02-11
Summary
Traditional sodalime CO2 absorbers are known to not only react with CO2 but also with sevoflurane. Therewith, a potentially harmful compound (compound A) is formed that can be nephrotoxic. In the United States, the sevoflurane manufacturer therefore recommends keeping the FGF (FGF) at \>2.0 L min-1 if a sodalime CO2 absorbent is used. Amsorb Plus® (Datex-Ohmeda Inc., Madison, WI, USA), is a novel type of CO2 absorbent that does not react with sevoflurane. This allows the FGF to be reduced to 0.5 L min-1. This has two important advantages: (i) less fresh sevoflurane is added to the circle system, and (ii) the sevoflurane that is in the system does not react with the CO2 absorber.
Sevoflurane is a potent greenhouse gas with a 100 year CO2-equivalents of 120. Measures that can reduce the consumption of volatile anaesthetics could make a significant contribution to reducing the carbon footprint of the operative process. Additionally, Amsorb Plus® canisters seem to have a longer life span than sodalime canisters and do not need to be disposed of via toxic waste stream, but via domestic waste.
In this study, we were interested if (i) the use of Amsorb Plus leads to a reduction in sevoflurane usage and therefore contribute to a reduction in the CO2 footprint of general anaesthesia with sevoflurane, (ii) Does the use of Amsorb Plus® lead to a reduction in the amount of (toxic) waste produced by operating theatres?
Comparator: a traditional sodalime CO2 absorber (Medisorb™ Multi-Absorber Original, CareFusion, Helsinki, Finland).
Conditions
- Anesthesia
Interventions
- OTHER
-
Comparing two CO2 absorbers in the ventilator circuit
General anaesthesia will be induced with a standardised regimen (propofol 0.8-2.5 mg·kg-1, sufentanil 0.2 - 0.5 µg·kg-1 and rocuronium 0.5 - 1 mg·kg-1). After tracheal intubation, anaesthesia will be maintained with sevoflurane targeted at 1 MAC end tidal concentration (corrected for age using the formula by Mapleson) in 40% O2. Different ventilator settings will be compared for 30 minutes (in randomised order): I. Sodalime, FGF 2.0 L min-1. II. Amsorb Plus®, FGF 2.0 L min-1. III. Soda lime, FGF, 0.5 L min-1. IV. Amsorb Plus®, FGF 0.5 L min-1. FGF=fresh gas flow.
Sponsors & Collaborators
-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-02-12
- Primary Completion
- 2020-05-29
- Completion
- 2020-05-29
Countries
- Netherlands
Study Locations
More Related Trials
-
The Effect of Sevoflurane on Cerebral CO2 Sensitivity and Systemic Arteries
NCT02054143 ·Status: COMPLETED ·Phase: PHASE4
-
Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol
NCT00586118 ·Status: COMPLETED
-
A Study Comparing Two Analgesia/Sedation Regimens, Remifentanil/Propofol Versus Sufentanil/Propofol In Mechanically Ventilated Intensive Care Patients Requiring Analgesia And Sedation.
NCT00421720 ·Status: TERMINATED ·Phase: PHASE4
-
The Optimal Dose of Sevoflurane Via Anaconda® in Post-operative Patient Underwent Head & Neck Surgery
NCT03559920 ·Status: COMPLETED ·Phase: NA
-
Effects of Sevoflurane Versus Desflurane Anesthesia Under Protective Mechanical Ventilation for Robotic Assisted Surgery
NCT07304479 ·Status: RECRUITING ·Phase: NA
-
Effect of Inhalation Sedation Compared With Propofol on the Sepsis-related Acute Respiratory Distress Syndrome Course
NCT04014218 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Anesthetic Choice (Sevoflurane Versus Desflurane) on Airway Reflex Recovery in the Context of Antagonized Neuromuscular Block
NCT01199237 ·Status: COMPLETED ·Phase: PHASE4
-
The Efficacy of Isocapnic Hyperpnoea to Accelerate Recovery After General Anesthesia With Sevoflurane
NCT00242671 ·Status: COMPLETED ·Phase: PHASE3
-
Ventilatory Effect on Speed of Anesthesia Under Various Inhaled Anesthetics
NCT01171833 ·Status: COMPLETED ·Phase: NA
-
Analgesia-First Sedation in Trauma Patients
NCT05751863 ·Status: RECRUITING ·Phase: NA
-
Comparison Between Inhalation and Intravenous Induction of Anaesthesia During Interventional Mitral Valve Repair
NCT04865614 ·Status: COMPLETED
-
Minimum Alveolar Concentration of Sevoflurane With Nitrous Oxide Inducing Isoelectric EEG
NCT01705743 ·Status: COMPLETED ·Phase: PHASE4
-
The Relationship of Sevoflurane Consumption With Metabolic Age
NCT06018597 ·Status: COMPLETED
-
Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11
NCT00000259 ·Status: COMPLETED ·Phase: NA
-
Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals
NCT02914119 ·Status: COMPLETED
-
Effect of Anesthetics on Microcirculation in Patients Undergoing Off-pump Coronary Artery Bypass Surgery
NCT03209193 ·Status: COMPLETED ·Phase: PHASE4
-
Sevoflurane, Propofol, Postoperative Pain
NCT01437462 ·Status: COMPLETED ·Phase: PHASE4
-
Adjunctive Esketamine for Analgesia in Mechanically Ventilated Septic Shock Patients
NCT05839366 ·Status: RECRUITING ·Phase: PHASE3
-
Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome
NCT02717780 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Two Bolus Doses of Remifentanil on the Incidence of Coughing During Emergence of Anesthesia
NCT01489072 ·Status: COMPLETED ·Phase: NA
-
Optimal Sevoflurane Concentration for Intubation in Combination of Clincal Remifentanil Doses
NCT02440204 ·Status: COMPLETED ·Phase: NA
-
CARbon Impact of aNesthesic Gas
NCT04163848 ·Status: COMPLETED
-
Renal Function During Pediatric Anesthesia
NCT02571426 ·Status: COMPLETED ·Phase: PHASE1
-
The Ratio of Hypnotic to Analgesic Potency of Volatile Anesthetics
NCT02698514 ·Status: COMPLETED ·Phase: PHASE3
-
Frequency of Airway Complications During General Anaesthesia After Introducing Five Handling Adaptations
NCT02743767 ·Status: COMPLETED ·Phase: NA